Related Experiment Video

Updated: Jun 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Adult treatment panel III and the management of dyslipidemia risk factors

Evan A Stein1

  • 1University of Cincinnati, Highland Heights, KY 41076, USA. esteinmrl@aol.com

Postgraduate Medicine
|August 12, 2009
PubMed

Insights

New cholesterol guidelines from the Third National Cholesterol Education Program Adult Treatment Panel III lower low-density lipoprotein targets to below 100 mg/dL. This change identifies more individuals needing intervention and aggressive cholesterol-lowering treatments.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Previous Adult Treatment Panel II (ATP II) guidelines informed cholesterol management.
  • Evolving understanding of cardiovascular disease risk necessitates updated recommendations.

Purpose of the Study:

  • To summarize the key changes in the Third National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines.
  • To highlight the implications of revised low-density lipoprotein (LDL) targets and the concept of coronary heart disease risk equivalents.

Main Methods:

  • Analysis of the Third National Cholesterol Education Program Adult Treatment Panel III (ATP III) report.
  • Comparison of ATP III recommendations with previous ATP II guidelines.

Main Results:

  • Lowered target for low-density lipoprotein (LDL) cholesterol to <100 mg/dL.
  • Introduction of the "coronary heart disease risk equivalent" concept.
  • Identification of a larger population requiring lipid-lowering interventions.

Conclusions:

  • The ATP III guidelines represent a significant shift in cholesterol management strategy.
  • More individuals will likely require pharmacotherapy and intensive lifestyle interventions to achieve new LDL goals.
  • The updated guidelines aim to reduce the burden of coronary heart disease through earlier and more aggressive treatment.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...